Alere Receives FDA CLIA Waiver for Alere™ i RSV Rapid Molecular Test

8 March 2017

Alere Inc., a global leader in rapid diagnostics, today announced that its Alere™ i RSV test has been granted CLIA (Clinical Laboratory Improvement Amendments) wa